Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Sandra L. Ross, Marika Sherman, Patricia L. McElroy, Julie A. Lofgren, Gordon Moody, Patrick A. Baeuerle, Angela Coxon, Tara Arvedson 2017. Bystander Receptor Blockade: IFN?R1, TNFRSF1A, ICAM-1 and FAS. protocols.io dx.doi.org/10.17504/protocols.io.hw8b7hwCopy Citation Copied
URL: https://dx.doi.org/10.17504/protocols.io.hw8b7hw
Authors: Sandra L. Ross, Marika Sherman, Patricia L. McElroy, Julie A. Lofgren, Gordon Moody, Patrick A. Baeuerle, Angela Coxon, Tara Arvedson
Summary: This protocol describes the use of neutralizing antibodies to block receptrs for assessing involvement in bystander killing by BiTE®-activated T cells.
Associated Publications: Ross SL, Sherman M, McElroy PL, Lofgren JA, Moody G, Baeuerle PA, Coxon A, Arvedson T, Bispecific T cell engager (BiTE) antibody constructs can mediate bystander tumor cell killing. PLoS ONE 12(8). doi: 10.1371/journal.pone.0183390
Affiliations: Department of Oncology Research, Amgen Inc., Department of Oncology Research, Amgen Inc., Department of Oncology Research, Amgen Inc., Department of Oncology Research, Amgen Inc., Department of Oncology Research, Amgen Inc., Department of Oncology Research, Amgen Inc., Department of Oncology Research, Amgen Inc., Department of Oncology Research, Amgen Inc.
External URL: https://doi.org/10.1371/journal.pone.0183390
Version: 1
Publication Date: 2017
Expand AllComing soon.
Source: Protocols.io